The ticking of the biological clock is especially loud in the ovaries — the organs that store and release a woman’s eggs. From age 25 to 40, a woman’s chance of conceiving each month decreases drastically.
For decades, scientists have pointed to declining egg quality as the main culprit. But new research from UC San Francisco and Chan Zuckerberg Biohub San Francisco shows that the story is bigger than the eggs: The surrounding cells and tissues of the ovary play a crucial role in how eggs mature and how quickly fertility wanes. The work is supported by the National Institutes of Health (NIH).
“We’ve long thought of ovarian aging as simply a problem of egg quality and quantity,” said Diana Laird, PhD, professor of Obstetrics, Gynecology & Reproductive Sciences at UCSF and senior author of the study, which appears in Science on Oct. 9. “What we’ve shown is that the environment around the eggs — the supporting cells, nerves, and connective tissue — is also changing with age.”
Understanding these changes may hold the key not only to extending fertility, but also to improving health. The risks of many age-related diseases rise after menopause or ovary removal, and slowing ovarian aging could help reduce these risks.
“By combining the Laird lab’s cutting-edge imaging with the Biohub’s expertise in two kinds of single-cell sequencing, we were able to understand the ovary in unprecedented detail,” said Norma Neff, PhD, director of the Genomics Platform at the San Francisco Biohub, who collaborated with Laird on the work. “This technology-driven approach let us uncover new cell types, providing a foundation for future discoveries in reproductive health.”
It takes an entire ecosystem to raise an egg
Laird and her colleagues set out to profile what normal aging looks like in the ovaries of mice and humans. First, they developed a new three-dimensional imaging technique that allowed them to visualize eggs in the ovaries without having to slice the organs into thin layers, as had been done before.
In mice that were the equivalent of 30 to 40 human years, they observed a dramatic drop in both immature resting eggs that are waiting in reserve and in growing eggs that are beginning to mature for ovulation. And just like women in their 30s, the mice did not conceive easily with in vitro fertilization (IVF).
When the scientists extended their 3D imaging to human ovaries, they uncovered an unexpected finding: Eggs are not evenly scattered throughout the ovary. Instead, they cluster in “pockets” surrounded by egg-free zones. With age, the density of eggs within these pockets declines.
“This was a surprise. We assumed eggs would be distributed more evenly based on what we see in the developing ovary,” said Laird, who is a Biohub investigator and a member of the Eli and Edythe Broad Center of Regeneration Medicine at UCSF. “These pockets suggest that even within one ovary, the environment around an egg may influence how long it lasts and how well it matures.”
New role for the nervous system in ovarian health
Next, the researchers teamed up with Neff’s group at the Biohub to study what genes were active in ovary cells as they aged. Ovarian tissue from humans is hard to come by, and eggs are large and incredibly fragile. So, instead of using standard miniature devices that separate and tag cells to sequence their active genes, the group painstakingly isolated individual eggs by hand to separate them from other cells.
After studying nearly 100,000 mouse and human cells, they identified 11 major cell types found in the ovaries, including one surprise: Glia, a type of support cell typically associated with nerves and most extensively studied in the brain, were in the ovaries.
At the same time, the study revealed that sympathetic nerves — the same nerves involved in the “fight or flight” response — form dense networks in ovaries that become even more dense with age. When the researchers ablated these nerves in mice, the animals had more eggs in reserve but fewer that matured, suggesting the nerves help decide when eggs start growing. Together, the observations on glia and sympathetic nerves suggest a new role for the nervous system in ovarian health.
Other support cells called fibroblasts also changed with age, triggering inflammation and scarring in the ovaries of women in their 50s — years earlier than such scarring appears in organs like the lungs or liver.
“This all points to a brand-new line of inquiry about how nerves, blood vessels, and other cell types communicate with eggs,” Laird said. “It tells us that ovarian aging is not just about the egg cells but about their whole ecosystem.”
Implications for fertility and beyond
For researchers, one of the most important takeaways of the new work is the similarity between human and mouse ovaries.
“Until now, it was somewhat unclear whether we could use mice as a model for humans when it comes to the ovaries — we have quite different reproductive windows,” Laird said. “But the similarities we saw in this study make us confident that we can move forward in mice and apply those lessons to humans.”
In addition, the new roadmap of healthy ovaries over time offers a starting place to ask how ovarian aging changes in different situations. Laird’s team is already launching studies probing whether some drugs could change the timing or speed of ovarian aging, she said. Ultimately, they hope to uncover ways to slow or delay ovarian aging, to impact both fertility and other diseases, like cardiovascular disease, which are common in women after menopause.
“The fountain of youth may actually be the ovary,” said Eliza Gaylord PhD, a postdoctoral fellow at UCSF who is co-first author of the study. “Delaying ovarian aging could promote healthier aging overall.”
Authors: Other authors of the study are Mariko H. Foecke, PhD, Ryan M. Samuel, PhD, Tara I. McIntyre, PhD, Juan Du, James M. Gardner, MD, PhD, and Faranak Fattahi, PhD, of UCSF; Angela M. Detweiler, Leah C. Dorman, Michael Borja, and Ritwicq Arjyal of Chan Zuckerberg Biohub San Francisco; Bikem Soygur, PhD, of the Buck Institute for Aging; and Amy E. Laird, PhD, of Oregon Health and Science University.
Funding: This work was funded by the National Institutes of Health (1F31HD108875, 1F31HD110208, 1R01GM122902, 1R01ES023297, P30ES030284), a UCSF Discovery Fellowship, a Hillblom/BARI Graduate Student Fellowship Award, CZ Biohub Investigator funds, The Global Consortium for Reproductive Health through the Bia-Echo Foundation (GCRLE-0123), the W.M. Keck Foundation, the Simons Foundation International, the Juno Fund, and individual donors including Mary Linda Laird, Robert and Mary Laird, and Nikki J. Zapol.
